Home/Filings/4/0001022079-22-000104
4//SEC Filing

RUSCKOWSKI STEPHEN H 4

Accession 0001022079-22-000104

CIK 0001022079other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:32 PM ET

Size

21.9 KB

Accession

0001022079-22-000104

Insider Transaction Report

Form 4
Period: 2022-05-25
RUSCKOWSKI STEPHEN H
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2022-05-25$142.13/sh900$127,921334,833 total
  • Sale

    Common Stock

    2022-05-25$141.36/sh2,565$362,591335,484 total
  • Exercise/Conversion

    Non-Qualifed Stock Option (right to buy)

    2022-05-25$86.63/sh14,854$1,286,8020 total
    Exercise: $86.63Exp: 2029-02-18Common Stock (14,854 underlying)
  • Exercise/Conversion

    Common Stock

    2022-05-25$86.63/sh+14,854$1,286,802349,687 total
  • Sale

    Common Stock

    2022-05-25$140.58/sh9,823$1,380,927339,864 total
  • Exercise/Conversion

    Common Stock

    2022-05-25$103.57/sh+10,037$1,039,532344,870 total
  • Sale

    Common Stock

    2022-05-25$140.60/sh6,821$959,046338,049 total
  • Exercise/Conversion

    Non-Qualifed Stock Option (right to buy)

    2022-05-25$103.57/sh10,037$1,039,5320 total
    Exercise: $103.57Exp: 2028-02-19Common Stock (10,037 underlying)
  • Sale

    Common Stock

    2022-05-25$142.15/sh651$92,540334,833 total
  • Sale

    Common Stock

    2022-05-25$141.35/sh4,131$583,909335,733 total
Footnotes (9)
  • [F1]This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022.
  • [F2]This transaction was executed in multiple trades at prices ranging from $140.02 to $141.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $141.03 to $142.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $142.09 to $142.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]This transaction was executed in multiple trades at prices ranging from $140.02 to $141.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F6]This transaction was executed in multiple trades at prices ranging from $141.02 to $141.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F7]This transaction was executed in multiple trades at prices ranging from $142.06 to $142.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F8]The options vested in three annual installments beginning with the first on February 19, 2019, the second on February 19, 2020 and the final on February 19, 2021.
  • [F9]The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022.

Issuer

QUEST DIAGNOSTICS INC

CIK 0001022079

Entity typeother

Related Parties

1
  • filerCIK 0001142624

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:32 PM ET
Size
21.9 KB